tumor necrosis factor receptor superfamily, member 5 (DBSS) |
CARBIMAZOLE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 1b |
CARBIMAZOLE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 1a |
CARBIMAZOLE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 4 |
CARBIMAZOLE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
CARBIMAZOLE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 8 |
CARBIMAZOLE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
melanocortin 5 receptor |
MINOXIDIL |
Melanocortin MC5 |
-16% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 2 |
FELODIPINE |
Adrenergic beta2 |
-16% |
NoneNone |
NoneNone |
View
|
dopamine receptor D4 |
FELODIPINE |
Dopamine D4.2 |
-16% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 2 |
IODOQUINOL |
Adrenergic beta2 |
-16% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 2 |
MC 258717 |
Adrenergic beta2 |
-16% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, beta |
N,N-DIMETHYLFORMAMIDE |
Chemokine CXCR2 (IL-8B) |
-16% |
NoneNone |
NoneNone |
View
|
adenosine A2a receptor |
4,4'-METHYLENEDIANILINE |
Adenosine A2A |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 1B |
INDINAVIR |
Serotonin 5-HT1B |
-16% |
NoneNone |
NoneNone |
View
|
tachykinin receptor 1 |
LORATADINE |
Tachykinin NK1 |
-16% |
NoneNone |
NoneNone |
View
|
matrix metallopeptidase 9 |
VINCRISTINE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-16% |
NoneNone |
NoneNone |
View
|
matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
VINCRISTINE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-16% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 5 (DBSS) |
4,4'-METHYLENEDIANILINE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 1b |
4,4'-METHYLENEDIANILINE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 1a |
4,4'-METHYLENEDIANILINE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 4 |
4,4'-METHYLENEDIANILINE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
4,4'-METHYLENEDIANILINE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 8 |
4,4'-METHYLENEDIANILINE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
METHYLPREDNISOLONE |
Protein Serine/Threonine Kinase, ERK2 |
-16% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
METHYLPREDNISOLONE |
Protein Serine/Threonine Kinase, ERK2 |
-16% |
NoneNone |
NoneNone |
View
|
A3 adenosine receptor |
METHYLPREDNISOLONE |
Adenosine A3 |
-16% |
NoneNone |
NoneNone |
View
|
estrogen receptor 1 |
MEXILETINE |
Estrogen ERalpha |
-16% |
NoneNone |
NoneNone |
View
|
caspase 7 |
IPRONIAZID |
Protease, Caspase 1 |
-16% |
NoneNone |
NoneNone |
View
|
caspase 6 |
IPRONIAZID |
Protease, Caspase 1 |
-16% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 5 |
GATIFLOXACIN |
Chemokine CCR5 |
-16% |
NoneNone |
NoneNone |
View
|
histamine receptor H 2 |
CARMUSTINE |
Histamine H2 |
-16% |
NoneNone |
NoneNone |
View
|
arachidonate 15-lipoxygenase, second type |
CARMUSTINE |
Lipoxygenase 15-LO |
-16% |
NoneNone |
NoneNone |
View
|
arachidonate 15-lipoxygenase |
CARMUSTINE |
Lipoxygenase 15-LO |
-16% |
NoneNone |
NoneNone |
View
|
arachidonate 15-lipoxygenase |
CARMUSTINE |
Lipoxygenase 15-LO |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 4 |
CLENBUTEROL |
Glutamate, Kainate |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 3 |
CLENBUTEROL |
Glutamate, Kainate |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 2 |
CLENBUTEROL |
Glutamate, Kainate |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 1 |
CLENBUTEROL |
Glutamate, Kainate |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 5 |
CLENBUTEROL |
Glutamate, Kainate |
-16% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
BALSALAZIDE |
Monoamine Oxidase MAOA |
-16% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
BALSALAZIDE |
Monoamine Oxidase MAOA |
-16% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, alpha |
OXYMETHOLONE |
Chemokine CXCR1(IL-8A) |
-16% |
NoneNone |
NoneNone |
View
|
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
LOXOPROFEN |
HMG-CoA Reductase |
-16% |
NoneNone |
NoneNone |
View
|
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
LOXOPROFEN |
HMG-CoA Reductase |
-16% |
NoneNone |
NoneNone |
View
|
guanylate cyclase A/atrial natriuretic peptide receptor (Non-specific probe) |
GALANTAMINE |
Atrial Natriuretic Factor (ANF) |
-16% |
NoneNone |
NoneNone |
View
|
natriuretic peptide receptor 3 |
GALANTAMINE |
Atrial Natriuretic Factor (ANF) |
-16% |
NoneNone |
NoneNone |
View
|
natriuretic peptide receptor 2 |
GALANTAMINE |
Atrial Natriuretic Factor (ANF) |
-16% |
NoneNone |
NoneNone |
View
|
melanocortin 5 receptor |
BENZOIC ACID |
Melanocortin MC5 |
-16% |
NoneNone |
NoneNone |
View
|
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
THIOGUANINE |
HMG-CoA Reductase |
-16% |
NoneNone |
NoneNone |
View
|
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
THIOGUANINE |
HMG-CoA Reductase |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
THIMEROSAL |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 1 |
THIMEROSAL |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, pi |
THIMEROSAL |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
AT hook, DNA binding motif, containing 1 (DBSS) |
THIMEROSAL |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, theta |
THIMEROSAL |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 2 |
THIMEROSAL |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
THIMEROSAL |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
THIMEROSAL |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
THIMEROSAL |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
THIMEROSAL |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
THIMEROSAL |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
THIMEROSAL |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, delta |
THIMEROSAL |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
THIMEROSAL |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 2 |
THIOGUANINE |
Adrenergic beta2 |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
BENAZEPRIL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
BENAZEPRIL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
BENAZEPRIL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
BENAZEPRIL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
BENAZEPRIL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
BENAZEPRIL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
BENAZEPRIL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 3 |
TAMOXIFEN |
Carbonic Anhydrase |
-16% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 2 |
TAMOXIFEN |
Carbonic Anhydrase |
-16% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 4 |
TAMOXIFEN |
Carbonic Anhydrase |
-16% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase XI |
TAMOXIFEN |
Carbonic Anhydrase |
-16% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase IX |
TAMOXIFEN |
Carbonic Anhydrase |
-16% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VIII |
TAMOXIFEN |
Carbonic Anhydrase |
-16% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VII |
TAMOXIFEN |
Carbonic Anhydrase |
-16% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VA, mitochondrial |
TAMOXIFEN |
Carbonic Anhydrase |
-16% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase IV |
TAMOXIFEN |
Carbonic Anhydrase |
-16% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase III, muscle specific |
TAMOXIFEN |
Carbonic Anhydrase |
-16% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase I |
TAMOXIFEN |
Carbonic Anhydrase |
-16% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase XIV |
TAMOXIFEN |
Carbonic Anhydrase |
-16% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VB, mitochondrial |
TAMOXIFEN |
Carbonic Anhydrase |
-16% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase XII |
TAMOXIFEN |
Carbonic Anhydrase |
-16% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VI |
TAMOXIFEN |
Carbonic Anhydrase |
-16% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase II |
TAMOXIFEN |
Carbonic Anhydrase |
-16% |
NoneNone |
NoneNone |
View
|
adenosine A2a receptor |
DIHYDROERGOTAMINE |
Adenosine A2A |
-16% |
NoneNone |
NoneNone |
View
|
opioid receptor, delta 1 |
TERAZOSIN |
Opiate delta |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
NETILMICIN |
Leukotriene C4 Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
NETILMICIN |
Leukotriene C4 Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
RILUZOLE |
HMG-CoA Reductase |
-15% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
STRONTIUM CHLORIDE HEXAHYDRATE |
Glutamate, NMDA, Agonism |
-15% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
STRONTIUM CHLORIDE HEXAHYDRATE |
Glutamate, NMDA, Agonism |
-15% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
STRONTIUM CHLORIDE HEXAHYDRATE |
Glutamate, NMDA, Agonism |
-15% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
DEFERIPRONE |
CYP450-3A4 Inhibition |
-15% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H, member 8 |
TIAPRIDE |
Potassium Channel HERG |
-15% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 6 |
TIAPRIDE |
Potassium Channel HERG |
-15% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
TIAPRIDE |
Potassium Channel HERG |
-15% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
TIAPRIDE |
Potassium Channel HERG |
-15% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 5 |
TIAPRIDE |
Potassium Channel HERG |
-15% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 3 |
TIAPRIDE |
Potassium Channel HERG |
-15% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 4 |
TIAPRIDE |
Potassium Channel HERG |
-15% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
TIAPRIDE |
Potassium Channel HERG |
-15% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
TIAPRIDE |
Potassium Channel HERG |
-15% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H, member 8 |
MINOXIDIL |
Potassium Channel HERG |
-15% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 6 |
MINOXIDIL |
Potassium Channel HERG |
-15% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
MINOXIDIL |
Potassium Channel HERG |
-15% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
MINOXIDIL |
Potassium Channel HERG |
-15% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 5 |
MINOXIDIL |
Potassium Channel HERG |
-15% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 3 |
MINOXIDIL |
Potassium Channel HERG |
-15% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 4 |
MINOXIDIL |
Potassium Channel HERG |
-15% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
MINOXIDIL |
Potassium Channel HERG |
-15% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
MINOXIDIL |
Potassium Channel HERG |
-15% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 2 |
2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN |
Muscarinic M2 |
-15% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 1 |
TRANS-PLATINUM(II)DIAMMINE DICHLORIDE |
Purinergic P2X |
-15% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 7 |
TRANS-PLATINUM(II)DIAMMINE DICHLORIDE |
Purinergic P2X |
-15% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X-like 1, orphan receptor |
TRANS-PLATINUM(II)DIAMMINE DICHLORIDE |
Purinergic P2X |
-15% |
NoneNone |
NoneNone |
View
|
bM410K19.2.2 (novel protein similar to extra-cellular matrix proteins and chondroitin sulfate proteoglycans, variant 2) (DBSS) |
MANGANESE (II) CHLORIDE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-15% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
PERHEXILINE |
Protein Serine/Threonine Kinase, p38alpha |
-15% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
PERHEXILINE |
Protein Serine/Threonine Kinase, p38alpha |
-15% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3 (formerly 2B), catalytic subunit, alpha isoform (calcineurin A alpha) |
MANGANESE (II) CHLORIDE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-15% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform (calcineurin A beta) |
MANGANESE (II) CHLORIDE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-15% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) |
MANGANESE (II) CHLORIDE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-15% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) |
MANGANESE (II) CHLORIDE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-15% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3, catalytic subunit, beta isoform |
MANGANESE (II) CHLORIDE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-15% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
BROMOBENZENE |
Monoamine Oxidase MAOA |
-15% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
BROMOBENZENE |
Monoamine Oxidase MAOA |
-15% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
PHENOL |
Leukotriene B4 |
-15% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
PHENOL |
Leukotriene B4 |
-15% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
PHENOL |
Leukotriene B4 |
-15% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
PHENOL |
Leukotriene B4 |
-15% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
BUPROPION |
Cyclooxygenase COX-2 |
-15% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
BUPROPION |
Cyclooxygenase COX-2 |
-15% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2a |
PHENOL |
Adrenergic alpha2A |
-15% |
NoneNone |
NoneNone |
View
|
FMS-like tyrosine kinase 1 |
IMATINIB |
Vascular Endothelinal Growth Factor (VEGF) |
-15% |
NoneNone |
NoneNone |
View
|
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
IMATINIB |
Vascular Endothelinal Growth Factor (VEGF) |
-15% |
NoneNone |
NoneNone |
View
|
FMS-like tyrosine kinase 1 |
NIACINAMIDE |
Vascular Endothelinal Growth Factor (VEGF) |
-15% |
NoneNone |
NoneNone |
View
|
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
NIACINAMIDE |
Vascular Endothelinal Growth Factor (VEGF) |
-15% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, beta |
RAMIPRIL |
Sodium Channel, Site 2 |
-15% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
PROCAINAMIDE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
PROCAINAMIDE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
PROCAINAMIDE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
PROCAINAMIDE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
PROCAINAMIDE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
PROCAINAMIDE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 4 |
LACIDIPINE |
Chemokine CCR4 |
-16% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3B |
PANTOPRAZOLE |
Phosphodiesterase PDE3 |
-16% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3A |
PANTOPRAZOLE |
Phosphodiesterase PDE3 |
-16% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
CANTHARIDIN |
Protein Serine/Threonine Kinase, ERK2 |
-16% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
CADMIUM CHLORIDE |
Serotonin Transporter |
-16% |
NoneNone |
NoneNone |
View
|
histamine receptor H 1 |
DEFERIPRONE |
Histamine H1, Central |
-16% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 2 |
CADMIUM CHLORIDE |
Adrenergic beta2 |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 5B |
PHENYLBUTAZONE |
Serotonin 5-HT4 |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 4 |
PHENYLBUTAZONE |
Serotonin 5-HT4 |
-16% |
NoneNone |
NoneNone |
View
|
angiotensin 1 converting enzyme 1 |
PHENYLHYDRAZINE |
Protease, Angiotensin Converting Enzyme |
-16% |
NoneNone |
NoneNone |
View
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
PHENYLHYDRAZINE |
Protease, Angiotensin Converting Enzyme |
-16% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 3 |
SODIUM ORTHOVANADATE |
Muscarinic M3 |
-16% |
NoneNone |
NoneNone |
View
|
tachykinin receptor 1 |
4-FLUORO-L-PHENYLALANINE |
Tachykinin NK1 |
-16% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3B |
POLYVINYLPYRROLIDONE |
Phosphodiesterase PDE3 |
-16% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3A |
POLYVINYLPYRROLIDONE |
Phosphodiesterase PDE3 |
-16% |
NoneNone |
NoneNone |
View
|
nitric oxide synthase 3 (endothelial cell) |
PHENYLBUTAZONE |
Nitric Oxide Synthase, Constitutive (cNOS) |
-16% |
NoneNone |
NoneNone |
View
|
nitric oxide synthase 3, endothelial cell |
PHENYLBUTAZONE |
Nitric Oxide Synthase, Constitutive (cNOS) |
-16% |
NoneNone |
NoneNone |
View
|
cysteinyl leukotriene receptor 1 |
PHENYLBUTAZONE |
Leukotriene D4 |
-16% |
NoneNone |
NoneNone |
View
|
cysteinyl leukotriene receptor 1 |
PHENYLBUTAZONE |
Leukotriene D4 |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
AMPIROXICAM |
Leukotriene C4 Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
AMPIROXICAM |
Leukotriene C4 Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, beta |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 1 |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 2 |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
amiloride-sensitive cation channel 5, intestinal |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 gamma |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 beta |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, gamma |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, delta |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type X, alpha |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage gated, type VIII, alpha |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
TRAZODONE |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
TRAZODONE |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
TRAZODONE |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|